Microchip Technology plans to close its Tempe, AZ plant in Q3 2025, affecting 500 employees, and lowers its Q3 revenue forecast. ⚠️ #MicrochipTechnology #Tempe #Manufacturing #TechNews #Q3Forecast #BusinessNews #EmploymentImpact #RevenueForecast

Cisco previously revised its revenue and profit forecasts for the full year, attributing the decline to slowing demand for networking equipment. Consequently, the company is expected to streamline its operating expenses through layoffs, a strategy employed by other tech giants like Alphabet, Amazon, and UPS. #CiscoSystems #BusinessRestructuring #Layoffs #RevenueForecast #OperatingExpenses #TechIndustry

As Cisco Systems restructures its business to target areas with higher growth potential, reports suggest that the company is preparing to lay off thousands of employees. An official announcement regarding the layoffs is anticipated following the release of the company's balance sheet on Wednesday. #CiscoSystems #BusinessRestructuring #Layoffs #RevenueForecast #OperatingExpenses #TechIndustry

Strong demand for Botox, generating $1.49 billion in quarterly revenue, persists despite intense competition. AbbVie's 2024 earnings per share forecast falls in the range of $11.05 - $11.25 billion, aligning with analyst estimates at the upper end of this range, specifically at $11.24. #AbbVie #FinancialResults #EarningsReport #Humira #ImmunologyProducts #Botox #RevenueForecast #2024Projection #MarketExpectations

The negative outlook stemming from CVS Health's decision to delist Humira poses a challenge, but AbbVie aims to counter the lost revenue with new immunology products Skyrizi and Rinvoq. In its 2027 projection, AbbVie raised the revenue forecast for these drugs from $21 billion to $27 billion.#AbbVie #FinancialResults #EarningsReport #Humira #ImmunologyProducts #Botox #RevenueForecast #2024Projection #MarketExpectations